Existing
colorectal cancer biomarkers are insufficient for providing a quick and accurate diagnosis, which is critical for a good prognosis. More appropriate
biomarkers are thus needed. To identify new
colorectal cancer biomarker candidates, we conducted a comprehensive differential proteomic analysis of six
cancer cell lines and a normal cell line, utilizing a fluorogenic derivatization-liquid chromatography-tandem mass spectrometry (FD-LC-MS/MS) approach. Two sets of intracellular
biomarker candidates were identified: one for
colorectal cancer, and the other for metastatic
colorectal cancer. Our results suggest that cooperative expression of FABP5 and
cyclophilin A might be linked to Her2 signaling. Upregulation of LDHB and downregulation of GAPDH suggest the existence of a specific nonglycolytic energy production pathway in metastatic
colorectal cancer cells. Downregulation of 14-3-3ζ/δ,
cystatin-B, Ran and
thioredoxin could be a result of their secretion, which then stimulates
metastasis via activity in the sera and ascitic fluids. We propose a possible flow scheme to describe the dynamics of
protein expression in
colorectal cancer cells leading to
tumor progression and
metastasis via cell proliferation, angiogenesis, disorganization of actin filaments and epithelial-mesenchymal transition. Our results suggest that
colorectal tumor progression may be regulated by signaling mediated by Her2,
hypoxia, and TGFβ.